FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On October 14, 2005
Table of Contents
Docket # Title
1976N-0052G OTC general comments & combinations
1995S-0316 75-Day Premarket Notifications for New Dietary Ingredients
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1999N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings
1999P-0033 Combat the spread of transmissible spongiform encephalopathy
2000D-1598 Voluntary Labeling for Bioengineered Foods
2000N-1396 Bioengineered Foods Consumed By Humans or Animals
2000P-1211 Establish Mandatory Pre-Market Safety Testing for GE Foods
2002D-0018 Race and Ethnicity Data in Clinical Trials for FDA
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2005N-0178 Agency Information Collection Activities; Proposed Collection; Comment Request; Regulations Under the Federal Import Milk Act
2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
2005N-0394 FDAs Communication of Drug Safety Information; Public Hearing
2005N-0404 Solicitation of Public Review and Comment on Research Protocol:
2005N-0416 Food Allergen Labeling Notification (FALN): Extensively Hydrolyzed Casein
2005P-0282 Require Health Messages on Soft Drinks
2005V-0415 performance standard for fluoroscopic equipment mfged by OrthoScan
1976N-0052G OTC general comments & combinations
EMC 1 S. Pursley Vol #: 35
1995S-0316 75-Day Premarket Notifications for New Dietary Ingredients
LET 12 HFS-800 to Cantox US Inc Vol #: 230
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 16634 Jarrow Formulas Vol #: 149
LET 16635 Jarrow Formulas Vol #: 149
LET 16636 Jarrow Formulas Vol #: 149
LET 16637 Jarrow Formulas Vol #: 149
LET 16638 Jarrow Formulas Vol #: 149
LET 16639 Jarrow Formulas Vol #: 149
LET 16640 Jarrow Formulas Vol #: 149
LET 16641 Jarrow Formulas Vol #: 149
LET 16642 Pharmanex, LLC Vol #: 149
LET 16643 Arkopharma, LLC Vol #: 149
LET 16644 Arkopharma, LLC Vol #: 149
1999N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings
EMC 4224 J. Hudson Vol #: 515
1999P-0033 Combat the spread of transmissible spongiform encephalopathy
EMC 1 Form Letter Vol #: 10
EMC 2 K. Martellaro Vol #: 9
EMC 3 K. West Vol #: 9
EMC 4 G. Schlegel Vol #: 9
EMC 5 L. Walzem Vol #: 9
2000D-1598 Voluntary Labeling for Bioengineered Foods
EMC 12025 B. Gallagher Vol #: 574
2000N-1396 Bioengineered Foods Consumed By Humans or Animals
EMC 11594 B. Gallagher Vol #: 349
2000P-1211 Establish Mandatory Pre-Market Safety Testing for GE Foods
EMC 5840 C. Craig Vol #: 789
EMC 5841 Consumers for Dental Choice Vol #: 789
EMC 5842 J. Hudson Vol #: 789
2002D-0018 Race and Ethnicity Data in Clinical Trials for FDA
EMC 7 B. Sachau Vol #: 2
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EMC 1136 I M Lawn Vol #: 11
EMC 1137 K M Holton Vol #: 11
EMC 1138 C R Shamel Vol #: 11
2005N-0178 Agency Information Collection Activities; Proposed Collection; Comment Request; Regulations Under the Federal Import Milk Act
N 2 FDA Vol #: 1
2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
EMC 185 B & J Stanfield Vol #: 3
EMC 186 Planned Parenthood of the Inland Northwest Vol #: 3
EMC 187 Planned Parenthood of the Rocky Mountains Vol #: 3
EMC 188 F Alterton RN Vol #: 3
EMC 189 N Dallas Vol #: 3
EMC 190 Planned Parenthood of Central Pennsylvania Vol #: 3
EMC 191 Northern Adirondack Planned Parenthood Vol #: 3
2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
APE 1 Alcon Surgical, IOL Marketing Vol #: 2
EAPE 158 Walker, Elizabeth Vol #: 2
EAPE 159 McLoudrey, Mark Vol #: 2
EAPE 160 Aikin, Kathryn Vol #: 2
EAPE 161 Wood, Greg Vol #: 2
EAPE 162 Davis, Kristin Vol #: 2
EAPE 163 Van Syckel, Lisa Vol #: 2
EAPE 164 Berry, Peggy Vol #: 2
EAPE 165 Dannemann, Eileen Vol #: 2
EAPE 166 Rillo, Julie Vol #: 2
EAPE 167 Spence, Michele Vol #: 2
EAPE 168 Vij, Kanika Vol #: 2
EAPE 169 Cannistraci, David Vol #: 2
EAPE 170 Benecchi, Chris Vol #: 2
EAPE 171 Yegen, Chris Vol #: 2
EAPE 172 Witczak, Kim Vol #: 2
EAPE 173 Katz, Daniel Vol #: 2
EAPE 174 Brooke, Shelagh Vol #: 2
EAPE 175 Goss, Catherine Vol #: 2
EAPE 176 Cannistraci, David Vol #: 2
EAPE 177 Gallauresi, Beverly Vol #: 2
EAPE 178 Gray, Catherine Vol #: 2
EAPE 179 Sugerman-Brozan, Alex Vol #: 2
EAPE 180 Schwamlein, Anna Vol #: 2
EAPE 181 Rich, Laura Vol #: 2
EAPE 182 Rieker, Denise Vol #: 2
EAPE 183 Browning, Crystal Vol #: 2
EAPE 184 Liversidge, Ellen Vol #: 2
EAPE 185 Zuckerman, Diana Vol #: 2
EAPE 186 Klar, Doedy Vol #: 2
EAPE 187 Allen, J. Aron Vol #: 2
EAPE 188 Bednarz, Bradley Vol #: 2
EAPE 189 Jans, Kristin Vol #: 2
EAPE 190 McKelvey, Stephen Vol #: 2
EAPE 191 Rothkopf, Carol Vol #: 2
EAPE 192 Hankin, Joan Vol #: 2
EAPE 193 Filmore, David Vol #: 2
EAPE 194 Jezarian, Wendy Vol #: 2
EAPE 195 Unterreiner, Mark Vol #: 2
EAPE 196 Frank, Lesley Vol #: 2
EAPE 197 Cobb, Mary Vol #: 2
EAPE 198 Day, Ruth Vol #: 2
EAPE 199 Rosa, David Vol #: 2
EAPE 200 Irons, Lea Vol #: 2
EAPE 201 Board Member, AARP Vol #: 2
EAPE 202 Ruskin, Gary Vol #: 2
EAPE 203 Baylor-Henry, JD, Minnie Vol #: 2
EAPE 204 Columbia-Walsh, Meg Vol #: 2
EAPE 205 Carpenter, Charles Vol #: 2
EAPE 206 Kastner, Kathy Vol #: 2
EAPE 207 Bolling, Jay Vol #: 2
EAPE 208 Rouleau, Gaetan Vol #: 2
EAPE 209 Arent, Jill Vol #: 2
EAPE 210 Shaw, Michael Vol #: 2
EAPE 211 Arent, JIll Vol #: 2
EAPE 212 Pietrowski, Mary Vol #: 2
EAPE 213 Board Member, AARP Vol #: 2
EAPE 214 Audet, Craig Vol #: 2
EAPE 215 Fogarty, Helen Vol #: 2
EAPE 216 javitt, gail Vol #: 2
EAPE 217 Holdsworth, Stacy Vol #: 2
EAPE 218 Brady, Patrick Vol #: 2
EAPE 219 Lassman, Scott Vol #: 2
EAPE 220 Stein, Gary Vol #: 2
EAPE 221 Allison-Ottey, Sharon Vol #: 2
EAPE 222 Allison-Ottey, Sharon Vol #: 2
EAPE 223 Czeizinger, Andrea Vol #: 2
EAPE 224 Burkholder, Rebecca Vol #: 2
EAPE 225 Krapf, David Vol #: 2
EAPE 226 Graham, Christopher Vol #: 2
EAPE 227 Mehta, Abhilasha Vol #: 2
EAPE 228 Mehta, Abhilasha Vol #: 2
EAPE 229 Shipley, Russell Vol #: 2
EAPE 230 Gardner, James Vol #: 2
EAPE 231 Mehta, Abhilasha (Abby) Vol #: 2
EAPE 232 Allison-Ottey, Sharon Vol #: 2
EAPE 233 Ziltz, Bob Vol #: 2
EAPE 234 Schuyler, Suzie Vol #: 2
EAPE 235 Sicola, Michelle Vol #: 2
EAPE 236 Solomon, Stefanie Vol #: 2
EAPE 237 Chon, Jin Vol #: 2
EAPE 238 Mayhew, Brian Vol #: 2
EAPE 239 Katzin, Lisa Vol #: 2
EAPE 240 Allen, Ingrid Vol #: 2
EAPE 241 Brachman, Dina Vol #: 2
EAPE 242 Machowsky, Martin Vol #: 2
EAPE 243 Gilgore, Lance Vol #: 2
EAPE 244 Slaughter, Edwin Vol #: 2
EAPE 245 Samp, Richard Vol #: 2
EAPE 246 Kastner, Kathy Vol #: 2
EAPE 247 walsh, laura Vol #: 2
EMC 4 USRA Respiratory - MIGU -PIE Vol #: 2
EMC 5 Pfizer Inc Vol #: 2
2005N-0394 FDAs Communication of Drug Safety Information; Public Hearing
APE 4 APhaRC LLC Vol #: 1
APE 5 Stephen A Goldman Consulting Services LLC Vol #: 1
APE 6 Public Citizen's Health Research Group Vol #: 1
EAPE 3 Berry, Peggy Vol #: 1
EAPE 4 Van Syckel, Lisa Vol #: 1
EAPE 5 Van Syckel, Lisa Vol #: 1
EAPE 6 Wade, Lindsey Vol #: 1
EAPE 7 Zuckerman, Diana Vol #: 1
EAPE 8 Frank, Lesley Vol #: 1
EAPE 9 Outterson, Kevin Vol #: 1
EAPE 10 Downing, Mathy Milling Vol #: 1
EAPE 11 Rothkopf, Carol Vol #: 1
EAPE 12 Jezarian, Wendy Vol #: 1
EAPE 13 Davidson, james H. Vol #: 1
EAPE 14 Pahl, Tish Vol #: 1
EAPE 15 Halpern, Naomi Vol #: 1
EAPE 16 Balmford, Kathryn Vol #: 1
EAPE 17 Edwards, John Vol #: 1
EAPE 18 Roberts, Michael Vol #: 1
EAPE 19 McNair, Douglas Vol #: 1
EAPE 20 Haughey, David Vol #: 1
2005N-0404 Solicitation of Public Review and Comment on Research Protocol:
N 1 FDA Vol #: 1
NM 1 FDA Vol #: 1
2005N-0416 Food Allergen Labeling Notification (FALN): Extensively Hydrolyzed Casein
APP 1 Mead Johnson Nutritionals Vol #: 1
2005P-0282 Require Health Messages on Soft Drinks
C 20 Community Health Improvement Project (CHIP) Vol #: 1
2005V-0415 performance standard for fluoroscopic equipment mfged by OrthoScan
ACK 1 HFA-305 to OrthoScan, Inc. Vol #: 1

Page created on October 27, 2005 dp

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management